OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Review on Approved and Inprogress COVID-19 Vaccines
Amir Farnudian-Habibi, Mobina Mirjani, Vahideh Montazeri, et al.
Deleted Journal (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 8
Amir Farnudian-Habibi, Mobina Mirjani, Vahideh Montazeri, et al.
Deleted Journal (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
Nanomaterials for mRNA ‐based therapeutics: Challenges and opportunities
Defeng Li, Qisong Liu, Meifeng Yang, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 36
Defeng Li, Qisong Liu, Meifeng Yang, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 36
Advances of Reverse Vaccinology for mRNA Vaccine Design against SARS-CoV-2: A Review of Methods and Tools
Maria Karolaynne da Silva, Daniel Melo de Oliveira Campos, Shopnil Akash, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2130-2130
Open Access | Times Cited: 12
Maria Karolaynne da Silva, Daniel Melo de Oliveira Campos, Shopnil Akash, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2130-2130
Open Access | Times Cited: 12
The Common Systemic and Local Adverse Effects of the Sinovac COVID-19 Vaccine: An Observational Study From Pakistan
Hira Khalid Chohan, Aisha Jamal, Muhammad Mubeen, et al.
Cureus (2023)
Open Access | Times Cited: 8
Hira Khalid Chohan, Aisha Jamal, Muhammad Mubeen, et al.
Cureus (2023)
Open Access | Times Cited: 8
mRNA PROTACs: engineering PROTACs for high‐efficiency targeted protein degradation
Xiaoqi Xue, Chen Zhang, Xiaolin Li, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 2
Xiaoqi Xue, Chen Zhang, Xiaolin Li, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 2
Preclinical Toxicity and Immunogenicity of a COVID-19 Vaccine (ZF2001) in Cynomolgus Monkeys
Hongzhong Yang, Wei Pan, Guoyu Chen, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2080-2080
Open Access | Times Cited: 7
Hongzhong Yang, Wei Pan, Guoyu Chen, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2080-2080
Open Access | Times Cited: 7
Extracellular Vesicle-Based SARS-CoV-2 Vaccine
Yasunari Matsuzaka, Ryu Yashiro
Vaccines (2023) Vol. 11, Iss. 3, pp. 539-539
Open Access | Times Cited: 3
Yasunari Matsuzaka, Ryu Yashiro
Vaccines (2023) Vol. 11, Iss. 3, pp. 539-539
Open Access | Times Cited: 3
Manifestations of excessive and systemic reactogenicity of vaccine, requirements for vaccination against new coronavirus infection
E. A. Medvedeva, К. А. Зыков, А.А. Плоскирева, et al.
Medical alphabet (2023), Iss. 11, pp. 35-43
Closed Access
E. A. Medvedeva, К. А. Зыков, А.А. Плоскирева, et al.
Medical alphabet (2023), Iss. 11, pp. 35-43
Closed Access
Evaluation of the Humoral Immune Response of Cattle Immunized with Inactivated Commercial Rabies Vaccine
Cleuza Santos Almeida, Wendell Marcelo de Souza Perinotto, Ângela Cristina de Oliveira Lima, et al.
(2023)
Closed Access
Cleuza Santos Almeida, Wendell Marcelo de Souza Perinotto, Ângela Cristina de Oliveira Lima, et al.
(2023)
Closed Access
